Japan Lifeline (7575) Q3 2026 earnings summary

Executive summary

• 9M FY2026 net sales reached a record ¥44,405mn, up 3.7% year over year, while operating profit fell 0.8% to ¥9,824mn and net income declined 3.5% to ¥6,821mn.

• Sales and operating profit were broadly in line with initial guidance; net income was slightly below plan due to discontinued-product expenses and head office relocation costs.

Financial highlights

• Gross profit rose 2.3% to ¥26,512mn; gross margin was 59.7%, down 80 bps year over year.

• Operating margin was 22.1%, down 100 bps, as higher SG&A outpaced gross profit growth; SG&A rose ¥684mn, including a ¥562mn increase in R&D.

• Ordinary profit fell 3.4% to ¥9,608mn, impacted by non-operating expenses related to discontinued products.

• Basic EPS was ¥97.25, down 2.1% year over year.

• Q3 sales reached a record ¥15,120mn, up 2.0% year over year, while net income fell 22.4%.

Outlook and guidance

• FY2026 guidance remains unchanged: net sales ¥59,300mn, operating profit ¥12,900mn, net income ¥9,350mn and EPS ¥133.30.

• Q4 sales and SG&A are expected to progress as planned; net income progress may be challenging due to one-time costs.

• Year-end dividend guidance is ¥54 per share, up ¥1 year over year; the payout ratio is forecast at ~40%.

• Medium-term targets include 7–8% average annual sales growth, 5–6% operating profit growth and FY2028 sales of ¥70bn.